Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-029990
Filing Date
2022-10-31
Accepted
2022-10-31 16:32:11
Documents
80
Period of Report
2022-07-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1867150
2 ex3-4.htm EX-3.4 201586
3 ex23-1.htm EX-23.1 3535
4 ex31-1.htm EX-31.1 18992
5 ex31-2.htm EX-31.2 18828
6 ex32-1.htm EX-32.1 7855
7 ex32-2.htm EX-32.2 4743
  Complete submission text file 0001493152-22-029990.txt   7082236

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncs-20220731.xsd EX-101.SCH 49658
9 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oncs-20220731_cal.xml EX-101.CAL 74512
10 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oncs-20220731_def.xml EX-101.DEF 185026
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncs-20220731_lab.xml EX-101.LAB 424555
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncs-20220731_pre.xml EX-101.PRE 324348
74 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 861051
Mailing Address 24 N. MAIN STREET PENNINGTON NJ 08534
Business Address 24 N. MAIN STREET PENNINGTON NJ 08534 (858) 210-7333
ONCOSEC MEDICAL Inc (Filer) CIK: 0001444307 (see all company filings)

EIN.: 980573252 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-54318 | Film No.: 221346452
SIC: 2834 Pharmaceutical Preparations